Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

RECRUITING

Penn State Cancer Institute, Hershey

RECRUITING

University of Virginia Health System, Charlottesville

RECRUITING

Virginia Commonwealth University, Richmond

RECRUITING

Moffit Cancer Center, Tampa

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

RECRUITING

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

RECRUITING

Univeristy of Wisconsin, Madison

RECRUITING

University of Minnesota, Minneapolis

RECRUITING

University of Illinois Cancer Center, Chicago

RECRUITING

University of Nebraska Medical Center, Omaha

RECRUITING

Providence Health & Services - Oregon, Portland

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick